The Niche Episode 075 – Roche – Novartis, Alphabet, Pfizer, Parthenon, Antios, Mission Bio, Section 32

Roche and Novartis part ways, Alphabet likes AI, Pfizer 89%, Series A, B, and the money that gets you there

Find out more at
https://thenichepod.com

Story References
Roche – Novartis
Alphabet
Pfizer
Parthenon
Antios
Mission Bio
Section 32

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

The Niche Episode 075 – Bonus Interview with Danielle Coe, Founder Black Women in Clinical Research

This week, we have a special bonus interview with Danielle Coe, founder of Black Women in Clinical Research.

Danielle Coe
Black Women in Clinical Research

Background

Danielle Coe started her career as a lab-based scientist, after learning from a friend about work in clinical research she pivoted her goals. It wasn’t immediate, but she eventually found her way into the industry and has forged a path on the site side clinical research. Through the process she was struck by the lack of women of color. To help decrease this gap and drive diversity through peer-to-peer support, Danielle created Black Women in Clinical Research. The goal? To help other black women start and build careers in clinical research through community support, resume crafting, interview preparation, negation tactics for salary, and more.  

Danielle carved time out of her busy schedule to share her story. I really appreciate the way she has turned the challenges she faced into a solution for others and her drive to provide practical solutions, not just nice ideas.

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

The Niche Episode 074 – Adamis, Genentech, Kerecis, Zerigo, Click, Agenus

Unique therapies including anti-opioid overdose, ocular implants, fish skin, UV light, digital therapeutics, and the impact of approvals

Find out more at
https://thenichepod.com

Story References
https://tinyurl.com/Niche-074-1
https://tinyurl.com/Niche-074-2
https://tinyurl.com/Niche-074-3
https://tinyurl.com/Niche-074-4
https://tinyurl.com/Niche-074-5
https://tinyurl.com/Niche-074-6
https://tinyurl.com/Niche-074-7
https://tinyurl.com/Niche-074-8

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

The Niche Episode 073 – Enzyvant, Charles River Laboratories, Merck (again), Regeneron

The 26-year pipeline, CMDO divestment, oncology, and movement among COVID19 Therapies
 

Find out more at
https://thenichepod.com

Story References
https://tinyurl.com/Niche-073-1
https://tinyurl.com/Niche-073-2
https://tinyurl.com/Niche-073-3
https://tinyurl.com/Niche-073-4
https://tinyurl.com/Niche-073-5
https://tinyurl.com/Niche-073-6

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries. 

The Niche Episode 072 – Ginkgo, Neumora, Pfizer, GSK, Intergalactic, Voyager

Less than spiffy SPACs, big brains big money, Malaria buzz, vaccines, tests, series A, and Voyager gets a renewed lease on life

Find out more at
https://thenichepod.com

Story References
https://tinyurl.com/Niche-072-1
https://tinyurl.com/Niche-072-2
https://tinyurl.com/Niche-072-3
https://tinyurl.com/Niche-072-4
https://tinyurl.com/Niche-072-5
https://tinyurl.com/Niche-072-6
https://tinyurl.com/Niche-072-7
https://tinyurl.com/Niche-072-8

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

The Niche Episode 071 – Merck (MSD), Merck KGaA, BioNTech, Kite

$11.5B acquisitions, we play “Who’s on First”, COVID19 therapy news, cancer Vaccines may be on the way, and CAR T for cancer is here to stay

Find out more at
https://thenichepod.com

Story References
https://tinyurl.com/Niche-071-1
https://tinyurl.com/Niche-071-2
https://tinyurl.com/Niche-071-3
https://tinyurl.com/Niche-071-4
https://tinyurl.com/Niche-071-5
https://tinyurl.com/Niche-071-6

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.